RFA-AI-24-041-Full-Announcement.html

This document is a Request for Applications (RFA) for the federal grant opportunity titled "Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Clinical Trial Not Allowed)". The purpose of this NOFO is to support exploratory and conceptual research projects focused on medical countermeasures, biodosimetry, and animal model development to diagnose, mitigate, and treat injuries arising from radiation exposure during a public health emergency.

The grant is being offered by the Department of Health and Human Services National Institutes of Health under the Allergy and Infectious Diseases Research program (CFDA 93.855). Eligible applicant types include other non-501(c)(3) nonprofits, city/township governments, for-profit organizations, 501(c)(3) nonprofits, higher education institutions (public), tribal governments, county governments, small businesses, and more. The total estimated funding available and anticipated number of awards are not specified. The application due date is June 30, 2024, and the earliest anticipated start date is April 2025.